EIF2AK3 and colonic neoplasm: In contrast, the sensibility of human colon cancer cells to 5-fluorouracil (5-FU) chemotherapy would recover after genetic or pharmacologic inhibition of the PERK-ATF4 pathway (Shi et al., 2019).